0001209191-18-005206.txt : 20180124
0001209191-18-005206.hdr.sgml : 20180124
20180124173538
ACCESSION NUMBER: 0001209191-18-005206
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180122
FILED AS OF DATE: 20180124
DATE AS OF CHANGE: 20180124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCGLYNN MARGARET G
CENTRAL INDEX KEY: 0001215126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18546162
MAIL ADDRESS:
STREET 1: C/O MERCK & CO INC
STREET 2: ONE MERCK DRIVE PO BOX 100
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889-0100
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-22
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001215126
MCGLYNN MARGARET G
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2018-01-22
4
M
0
10000
59.55
A
16217
D
Common Stock
2018-01-22
4
S
0
10000
160.00
D
6217
D
Common Stock
2018-01-23
4
M
0
10000
59.55
A
16217
D
Common Stock
2018-01-23
4
S
0
10000
165.00
D
6217
D
Stock Option (Right to Buy)
59.55
2018-01-22
4
M
0
10000
0.00
D
2022-05-31
Common Stock
10000
10000
D
Stock Option (Right to Buy)
59.55
2018-01-23
4
M
0
10000
0.00
D
2022-05-31
Common Stock
10000
0
D
Transaction made pursuant to Ms. MsGlynn's company-approved trading plan under Rule 10b5-1.
Fully vested.
/s/ Omar White, Attorney-in-Fact
2018-01-24